4.7 Review

The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: a systematic review and meta-analysis

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2022.11.043

关键词

Undernutrition; MDR-TB; Sputum culture conversion; Treatment outcomes; Meta-analysis

向作者/读者索取更多资源

This study aimed to evaluate the effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis. The results showed that undernutrition was significantly associated with a longer time to sputum culture conversion, higher mortality rate, and unsuccessful treatment outcomes.
Objectives: We aimed to evaluate the effect of undernutrition on sputum culture conversion and treat-ment outcomes among people with multidrug-resistant tuberculosis (MDR-TB).Methods: We searched for publications in the Medline, Embase, Scopus, and Web of Science databases. We conducted a random-effect meta-analysis to estimate the effects of undernutrition on sputum culture conversion and treatment outcomes. Hazard ratio (HR) for sputum culture conversion and odds ratio (OR) for end-of-treatment outcomes, with 95% CI, were used to summarize the effect estimates. Potential publication bias was checked using funnel plots and Egger's tests.Results: Of the 2358 records screened, 63 studies comprising a total of 31,583 people with MDR-TB were included. Undernutrition was significantly associated with a longer time to sputum culture conversion (HR 0.7, 95% CI 0.6-0.9, I 2 = 67 middot1%), and a higher rate of mortality (OR 2.8, 95% CI 2.1-3.6, I 2 = 21%) and unsuccessful treatment outcomes (OR 1.8, 95% CI 1.5-2.1, I 2 = 70%). There was no significant publication bias in the included studies.Conclusion: Undernutrition was significantly associated with unsuccessful treatment outcomes, including mortality and longer time to sputum culture conversion among people with MDR-TB. These findings have implications for supporting targeted nutritional interventions alongside standardized TB drugs.(c) 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据